OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells
Yaxin Sun, Beibei Sha, Wenjing Huang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 7-8, pp. 545-560
Closed Access | Times Cited: 16
Yaxin Sun, Beibei Sha, Wenjing Huang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 7-8, pp. 545-560
Closed Access | Times Cited: 16
Showing 16 citing articles:
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy
Peng Huang, Yuhan Wang, Pengfei Zhang, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 2953-2966
Closed Access | Times Cited: 15
Peng Huang, Yuhan Wang, Pengfei Zhang, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 2953-2966
Closed Access | Times Cited: 15
Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion
Sheng‐Kai Hsu, Chon‐Kit Chou, I‐Ling Lin, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Sheng‐Kai Hsu, Chon‐Kit Chou, I‐Ling Lin, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPβ) stability and accelerates adipogenesis and lipid accumulation
Myung Sup Kim, Jung-Hwan Baek, JinAh Lee, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 11
Myung Sup Kim, Jung-Hwan Baek, JinAh Lee, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 11
The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy
Xinlan Hu, Yan Wu, Mengmeng Yao, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 329-345
Closed Access
Xinlan Hu, Yan Wu, Mengmeng Yao, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 329-345
Closed Access
LncRNA OLMALINC promotes osteosarcoma progression through USP1-mediated autophagy suppression
Jianping Li, Bo Yu, Zhaowen Xue, et al.
Human Cell (2025) Vol. 38, Iss. 3
Closed Access
Jianping Li, Bo Yu, Zhaowen Xue, et al.
Human Cell (2025) Vol. 38, Iss. 3
Closed Access
Deubiquitinases as novel therapeutic targets for diseases
Yali Xian, Jing Ye, Yu Tang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 3
Yali Xian, Jing Ye, Yu Tang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 3
The role of USP1 deubiquitinase in the pathogenesis and therapy of cancer
Svitlana Antonenko, М.П. Завелевич, Г. Д. Телегеев
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 9
Svitlana Antonenko, М.П. Завелевич, Г. Д. Телегеев
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 9
Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses
Niloufar A. Boghdeh, Brittany McGraw, Michael D. Barrera, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 655-655
Open Access | Times Cited: 8
Niloufar A. Boghdeh, Brittany McGraw, Michael D. Barrera, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 655-655
Open Access | Times Cited: 8
Targeting deubiquitinases for cancer therapy
Qian Xue, Daolin Tang, Xin Chen, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 4
Qian Xue, Daolin Tang, Xin Chen, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 4
Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing C-myc
Xia Zhang, Peng Peng, Liwei Bao, et al.
(2024)
Open Access | Times Cited: 1
Xia Zhang, Peng Peng, Liwei Bao, et al.
(2024)
Open Access | Times Cited: 1
Targeting and degradation of OTUB1 by Erianin for antimetastasis in esophageal squamous cell carcinoma
Yuan Zhu, Ningning Kang, Li Zhang, et al.
Phytomedicine (2024) Vol. 135, pp. 155969-155969
Closed Access
Yuan Zhu, Ningning Kang, Li Zhang, et al.
Phytomedicine (2024) Vol. 135, pp. 155969-155969
Closed Access
CXCR4 up‐regulation mediated by USP1 deubiquitination promotes the tumorigenesis and immune escape in esophageal squamous‐cell carcinoma
Liang Xiao, Haixia Xu, Meixiang Li, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 11
Open Access
Liang Xiao, Haixia Xu, Meixiang Li, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 11
Open Access
Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC
Xia Zhang, Peng Peng, Liwei Bao, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1798-1798
Open Access
Xia Zhang, Peng Peng, Liwei Bao, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1798-1798
Open Access
The Deubiquitinating Enzyme USP1 is Auto-Ubiquitinated and Destabilized by ML323 in Colorectal Cancer Cells
yili yang
Eurasian Journal of Medicine and Oncology (2023)
Open Access | Times Cited: 1
yili yang
Eurasian Journal of Medicine and Oncology (2023)
Open Access | Times Cited: 1
Rising impact of cell death research
Patrycja Nowak‐Sliwinska, Arjan W. Griffioen
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1503-1504
Open Access | Times Cited: 1
Patrycja Nowak‐Sliwinska, Arjan W. Griffioen
APOPTOSIS (2023) Vol. 28, Iss. 11-12, pp. 1503-1504
Open Access | Times Cited: 1
Deubiquitinase USP1 enhances CCAAT/enhancer-binding protein beta (C/EBPβ) stability and accelerates adipogenesis and lipid accumulation
Kyung–Hee Chun, Myung Sup Kim, Jung-Hwan Baek, et al.
Research Square (Research Square) (2023)
Open Access
Kyung–Hee Chun, Myung Sup Kim, Jung-Hwan Baek, et al.
Research Square (Research Square) (2023)
Open Access
